Ivermectin induced Steven–Johnsons syndrome: case report

Abstract Background Stevens–Johnson syndrome is one of the manifestations of mucocutaneous adverse drug reactions. Although antimicrobials are responsible for greater than 50% of these adverse drug reactions, there is no documented case implicating ivermectin as the culprit. Case summary A 38 year o...

Full description

Bibliographic Details
Main Authors: Desmond Aroke, Diego Nitcheu Tchouakam, Alexis Tazinya Awungia, Sylvester Yari Mapoh, Stewart Ndutard Ngassa, Benjamin Momo Kadia
Format: Article
Language:English
Published: BMC 2017-05-01
Series:BMC Research Notes
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13104-017-2500-5
_version_ 1818251540348010496
author Desmond Aroke
Diego Nitcheu Tchouakam
Alexis Tazinya Awungia
Sylvester Yari Mapoh
Stewart Ndutard Ngassa
Benjamin Momo Kadia
author_facet Desmond Aroke
Diego Nitcheu Tchouakam
Alexis Tazinya Awungia
Sylvester Yari Mapoh
Stewart Ndutard Ngassa
Benjamin Momo Kadia
author_sort Desmond Aroke
collection DOAJ
description Abstract Background Stevens–Johnson syndrome is one of the manifestations of mucocutaneous adverse drug reactions. Although antimicrobials are responsible for greater than 50% of these adverse drug reactions, there is no documented case implicating ivermectin as the culprit. Case summary A 38 year old adult Cameroonian male presented to our health facility with facial rash, painful oral sores, black eschars on lips and red tearing eyes 3 days following ingestion of ivermectin received during a nationwide anti-filarial campaign. He had no known chronic illness, no known allergies and was not on any medications prior to the campaign. Physical examination revealed discharging erythematous eyes, crusted and blister-like lesions with cracks on his lips and oral mucosa. His laboratory tests were unremarkable but for a positive Human Immunodeficiency Virus (HIV) test. A diagnosis of Ivermectin induced Stevens–Johnson syndrome in a newly diagnosed HIV patient was made. The patient was managed with supportive therapy and the evolution thereafter was favourable. Conclusion Stevens–Johnson syndrome is a potential side effect of ivermectin and susceptibility to this adverse effect may be increased in HIV infection.
first_indexed 2024-12-12T16:09:54Z
format Article
id doaj.art-340becb81f1f45808d238efaf3b0cab9
institution Directory Open Access Journal
issn 1756-0500
language English
last_indexed 2024-12-12T16:09:54Z
publishDate 2017-05-01
publisher BMC
record_format Article
series BMC Research Notes
spelling doaj.art-340becb81f1f45808d238efaf3b0cab92022-12-22T00:19:12ZengBMCBMC Research Notes1756-05002017-05-011011410.1186/s13104-017-2500-5Ivermectin induced Steven–Johnsons syndrome: case reportDesmond Aroke0Diego Nitcheu Tchouakam1Alexis Tazinya Awungia2Sylvester Yari Mapoh3Stewart Ndutard Ngassa4Benjamin Momo Kadia5Nkwen Baptist Health CenterHealth and Human Development (2HD) Research GroupMboppi Baptist HospitalUniversite Libre BrusselsBali Kumbat Sub-Divisional HospitalPresbyterian General Hospital Acha-TugiAbstract Background Stevens–Johnson syndrome is one of the manifestations of mucocutaneous adverse drug reactions. Although antimicrobials are responsible for greater than 50% of these adverse drug reactions, there is no documented case implicating ivermectin as the culprit. Case summary A 38 year old adult Cameroonian male presented to our health facility with facial rash, painful oral sores, black eschars on lips and red tearing eyes 3 days following ingestion of ivermectin received during a nationwide anti-filarial campaign. He had no known chronic illness, no known allergies and was not on any medications prior to the campaign. Physical examination revealed discharging erythematous eyes, crusted and blister-like lesions with cracks on his lips and oral mucosa. His laboratory tests were unremarkable but for a positive Human Immunodeficiency Virus (HIV) test. A diagnosis of Ivermectin induced Stevens–Johnson syndrome in a newly diagnosed HIV patient was made. The patient was managed with supportive therapy and the evolution thereafter was favourable. Conclusion Stevens–Johnson syndrome is a potential side effect of ivermectin and susceptibility to this adverse effect may be increased in HIV infection.http://link.springer.com/article/10.1186/s13104-017-2500-5IvermectinStevens–Johnson syndrome (SJS)Human immunodeficiency virus (HIV)
spellingShingle Desmond Aroke
Diego Nitcheu Tchouakam
Alexis Tazinya Awungia
Sylvester Yari Mapoh
Stewart Ndutard Ngassa
Benjamin Momo Kadia
Ivermectin induced Steven–Johnsons syndrome: case report
BMC Research Notes
Ivermectin
Stevens–Johnson syndrome (SJS)
Human immunodeficiency virus (HIV)
title Ivermectin induced Steven–Johnsons syndrome: case report
title_full Ivermectin induced Steven–Johnsons syndrome: case report
title_fullStr Ivermectin induced Steven–Johnsons syndrome: case report
title_full_unstemmed Ivermectin induced Steven–Johnsons syndrome: case report
title_short Ivermectin induced Steven–Johnsons syndrome: case report
title_sort ivermectin induced steven johnsons syndrome case report
topic Ivermectin
Stevens–Johnson syndrome (SJS)
Human immunodeficiency virus (HIV)
url http://link.springer.com/article/10.1186/s13104-017-2500-5
work_keys_str_mv AT desmondaroke ivermectininducedstevenjohnsonssyndromecasereport
AT diegonitcheutchouakam ivermectininducedstevenjohnsonssyndromecasereport
AT alexistazinyaawungia ivermectininducedstevenjohnsonssyndromecasereport
AT sylvesteryarimapoh ivermectininducedstevenjohnsonssyndromecasereport
AT stewartndutardngassa ivermectininducedstevenjohnsonssyndromecasereport
AT benjaminmomokadia ivermectininducedstevenjohnsonssyndromecasereport